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Abstract
Background: The aim of the present study was to investigate the effect of heparin (1000 IU/mL) in the blood sample on
the results of venous blood gases of patients admitted to the cardiac intensive care unit.
Materials and methods: The present double-blind randomized clinical trial study was performed on 282 samples from 141
patients admitted to the cardiac intensive care unit. Insulin syringes with heparin (1000 IU/mL) and heparin (5000 IU/mL) and
1 cc of blood sample were taken from the peripheral vein, then distributed in two syringes and given to the analyzer.
Results: In the present study, the mean age of the samples was 49.96 ± 9.58. There was a statistically signiﬁcant difference between the two groups in terms of values of partial pressure of carbon dioxide (PCO2) (P < 0.001), partial
pressure of oxygen (PaO2) (P < 0.001), blood oxygen saturation (P < 0.001), bicarbonate ion (P < 0.001), excess base
(P < 0.001), hemoglobin (P < 0.001), calcium (P < 0.001), potassium (P < 0.001), and sodium (P < 0.001) in the two groups.
Conclusion: Overall, heparin (1000 IU/mL) led to a less disruption in the results of venous blood gases, and since it has
not signiﬁcantly increased the risk of clots, it is recommended to be used for venous blood gas sampling.
Keywords: Venous blood gases, Heparin concentration, Electrolytes

1. Introduction

B

lood gas (BG) analysis is an essential part in
diagnosing and managing changes in respiratory and metabolic parameters of critically ill patients and is an important tool for anesthesiologists
and intensive care unit nurses [1]. Arterial blood gas
(ABG) measurement is the most common test in
intensive care units, but its blood sampling is invasive and painful and is associated with complications such as thrombosis, embolism, hematoma,
aneurysm, distal ischemia, and infection [2-5]. It also
causes needlestick injuries and subsequent exposure to the human immunodeﬁciency virus (HIV)
and hepatitis among the medical staff [6]. When
ABG measurement is difﬁcult and technically

impossible, the alternative method is to measure
venous blood gases (VBG) [7].
The correctness of a BG test depends on the correct collection and analysis of blood samples, and
laboratory errors account for most of medical errors
[8]. However, in the case of VBG, many errors occur
before analysis and when collecting blood samples
that leads to incorrect concentrations of blood gases
[9]. The efﬁciency of this diagnostic tool depends on
the sampling accuracy, the syringe volume, the
amount of blood sample, the type and amount of
heparin, storage, and timing of sending the sample
to interpret the results correctly. Although previous
studies have shown that heparin may lead to errors
in the blood gas processing, it is still considered the
only suitable anticoagulant in BG analysis [10].
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One of the most common practical problems
related to VBG analysis is insufﬁcient anticoagulation and the formation of small blood clots,
which can lead to obstruction of the sampling path
of analyzers and invalid results [11-14]. The minimum volume required for the analysis of BG parameters is 0.3 ml. Adding too much liquid heparin
(sodium or calcium) to the blood sample can lead to
positive bias by binding to positive ions and lead to
negative bias by increasing the acidity level of the
blood gases and the diluting blood sample [12, 15,
16]. Electrolytes and partial pressure of carbon dioxide (PCO2) seem to be dilution-sensitive variables, while the logarithm of the hydrogen ion
concentration (pH) and the partial pressure of oxygen (PO2) are not signiﬁcantly affected [17, 18].
Ionized calcium is more affected by the binding of
heparin salts, although sodium and potassium may
also be affected [19-21].
The Clinical and Laboratory Standards Institute
(CLSI) and American Association for Respiratory
Care (AARC) have published guidelines for the BG
analysis that do not state the collection of blood in
liquid heparinized syringes; however, they do warn
the dilution and chemical effects of liquid heparin in
BG tests [18, 22, 23]. Moreover, despite all these
releases, non-standard BG sampling using liquid
heparin (especially different sizes of syringes, needles and collecting different blood samples) is used
to ensure patient comfort, it's easier use or unawareness of its effects [18, 24].
Considering the lack of standard protocols in
reference books and different sampling methods (in
terms of BG sample volume and heparin concentration for heparinizing syringes, different sizes of syringes and needles) and due to reduced combined
effects and dilution in lower heparin concentration on
BG results and comparing the incidence of clot formation in the two groups, the researcher decided to
compare the effect of heparin (1000 IU/mL) and
heparin (5000 IU/mL) on results of venous blood gas.

2. Materials and methods
The present double-blind randomized clinical trial
was performed on 282 samples from 141 patients (2
samples from each patient) admitted to the intensive
care unit (CCU) of 22 Bahman Hospital in Neyshabur
in 2020. Inclusion criteria included: informed and
written consent to participate in the study, CCU
admission, and patients aged 18-60 years, hemoglobin concentration more than 10 mg/dl, included
patients used anticoagulants, and antiplatelet.
After obtaining informed written consent from
each of the research subjects, the eligible individuals
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were selected using convenience sampling method
and sampling was continued until achieving the
desired sample size. Data collection tools included
demographic information form, intravenous blood
gas results checklist, and blood gas test analyzer.
First, the demographic information form was
completed by the researcher in the form of face-toface interviews with the research subjects.
For intravenous sampling, insulin heparinized
syringes were coded as A (heparin 1000 IU/mL) and
B (heparin 5000 IU/mL) and the samples were
numbered from 1 to 141 in each group. The reliability of insulin syringes was evaluated using ten
syringes by ﬁlling and emptying them and
measuring different concentrations of heparin
remaining in the dead space of the syringe and
needle. The samples were divided into two groups:
1000 IU/mL heparinized syringes and 5000 IU/mL
heparinized syringes, which is the common heparinization method. Equal number of insulin syringes were heparinized by the researcher in one
group (intervention group: A) with heparin 1000 IU/
mL solution (to prepare heparin 1000 IU/mL, dilute
one unit of heparin 1000 IU/mL with 4 cc of distilled
water in a 5 cc syringe and increase its volume to
5 cc, each cc of which is equal to 1000 units), at the
rate of 0.05 cc and with the same concentration of
heparin 1000 IU/mL (0.05 cc) in the other group
(control group: B). The syringe plunger was pulled
back to the end once, so that their inner surface was
heparinized. Then, the heparin was emptied once
by pulling back the plunger forward. In order to
maintain the same condition, two blood samples
were taken from the peripheral venous line in terms
of all possible confounding factors and homogenization of the two groups. In this regard, after taking
1 cc (100 units) of blood sample using a 100-unit
syringe, equal blood samples (0.5 cc or 50 units per
syringe) were divided in two heparinized insulin
syringes: A (heparin 1000 IU/ml) and B (heparin
5000 IU/ml) and then placed on ice and sent to the
laboratory within 10 minutes [10] along with the test
sheet, in which the necessary parameters (patient
demographic characteristics, body temperature,
hemoglobin level, oxygen intake) were recorded. It
should be noted that only the researcher knew
about the nature syringe codes and grouping. Before
sending the sample to the laboratory, attempts were
made to ensure the absence of clots in the samples
and if any clot was seen in the syringe, the results
were recorded in the checklist to compare the two
groups in terms of clot formation. Since clots cause
damage to the device and the clot formation can be
due to the use of inappropriate or insufﬁcient anticoagulant or non-combination of heparin with the
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blood sample, therefore, the blood sample syringe
was rolled or inverted between the palms of the
sampler for 1 minute or 10 times before being given
to the analyzer. Before analyzing the samples, the
correct operation of the analyzer was conﬁrmed by
operator (calibration with three standard solutions
of alkalosis, acidosis and normal, automatically
during ﬁrst 15 minutes in the morning and night
shifts and manually after seeing each clot in the
sample). The samples were given to a Medica Easy
static analyzer (the USA) by a laboratory expert who
did not know about heparinized syringes and codes
A and B. It should be noted that the analysis time
lasted for two consecutive minutes (syringes were
placed randomly inside the device because there
was a two-minute interval between their analysis).
Demographic information of each patient was
recorded in a questionnaire and checklist related to
venous blood gas results. It should be noted that
there were blood clots in four heparin (1000 IU/ml)
syringes and one heparin (5000 IU/ml) syringe
Fig. 1.

BioMedicine
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2.1. Ethical consideration
The present study was registered in the Iranian
Registry of Clinical Trials with the code
(IRCT20200929048885N1) and was approved by the
Ethics Committee of the Shaheed rajaei's Cardiovascular Center with the number (IR.RHC.REC.1399.064). CONSORT checklist was use to
report the study [25].
The collected data were analyzed using SPSS ver.
20 and descriptive statistics and paired t-test and
Wilcoxon t-test. P-value0.05 was considered as the
signiﬁcant level.

3. Results
The present study was carried out on 141 people,
including 60 women (42.6%) and 81 men (57.4%)
with a mean age of 49.96 ± 9.58 years and a body
temperature of 37.1 ± 0.35. With regard to demographic characteristics, 111 (78.7%) of the subjects were married and 47 (33.3%) were housewives.

Fig. 1. CONSORT 2010 ﬂow diagram.
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Also, 32.6% of people were illiterate, 112 people
(79.4%) had no smoking and 83 people (58.9%) had
acute coronary syndrome. Past medical history includes 71 patients with hypertension, 53 patients
with diabetes, 8 patients with hyperthyroidism, 89
patients with hyperlipidemia, 18 patients with renal
failure and 6 patients on dialysis, 41 patients with
angioplasty, 5 patients with coronary artery bypass
graft surgery, 1 patient with surgery Brain tumor
and 4 patients had cancer. Patients presenting with
arrhythmias often had a history of hyperthyroidism
and renal failure. The most prevalent type of ACS
was NSTEMI (n ¼ 54), the most prevalent type of
arrhythmia was atrial ﬁbrillation. The preexisting
disease for pulmonary edema was CHF (Table 1).
The results of paired t-test showed no signiﬁcant
difference between the pH values of heparin (5000
IU/ml) samples and heparin (1000 IU/ml) samples
(P ¼ 0.98). The results of paired t-test also showed a
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signiﬁcant difference between PCO2, oxygen saturation (SO2), bicarbonate ion (HCO3), base excess
(BE), hemoglobin and electrolytes (sodium, potassium and calcium) of heparin (5000 IU/ml) samples
and heparin (1000 IU/ml) samples (P < 0.001). In
other words, levels of PCO2, bicarbonate ion
(HCO3), base excess (BE), potassium and calcium
were higher in the heparin (1000 IU/ml) group than
the heparin (5000 IU/ml) group. Also, levels of PO2,
blood oxygen saturation (SO2), hemoglobin, and
sodium were higher in the heparin (5000 IU/ml)
group than in the heparin (1000 IU/ml) group
(Tables 2 and 3).
The results of McNemar test showed no signiﬁcant difference between the formation of clots in
heparin (5000 IU/mL) samples and heparin (1000
IU/mL) (P ¼ 0.25). There was one clot case in heparin (5000 IU/mL) samples and four clot cases in
heparin (1000 IU/mL) samples. There was a

Table 1. Frequency distribution of studied demographic and clinical variables.
Variable
Sex
Level of education

Job

Marital status

Smoking
Past Medical History

Diagnosis

Male
Female
Illiterate
High school
Diploma
University
Employee
Self-employed
Unemployed
Housewife
Student
Single
Married
Divorced
Deceased spouse
Yes
No
Hypertension
Diabetes
Hyperlipidemia
Hyperthyroidism
renal failure and patients on dialysis
Angioplasty
CABG
surgery Brain tumor
cancer
No past medical history
Acute coronary syndrome
NSTEMI
STEMI
unstable angina
Heart failure
Pulmonary edema
Arrhythmia
(Atrial ﬁbrillation
Atrial ﬂutter
supraventricular tachycardia)

Number

Percentage

Total number (percentage)

81
60
46
28
31
36
25
37
23
47
9
12
111
4
14
29
112
71
53
89
8
24
41
5
1
4
35
83
45
20
18
22
14
22
10
5
7

57.4
42.6
32.6
19.9
22
25.5
17.7
26.2
16.3
33.3
6.4
8.5
78.7
2.8
9.9
20.6
79.4
50.3%
37.5%
63.1%
5.6%
17%
29%
3.54%
0.7%
2.83%
24.8
58.9
54.3
24
21.7
15.6
9.9
15.6
45.4
22.7
31.8

141 (100)
141 (100)

141 (100)

141 (100)

141 (100)
141 (100)

141 (100)
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Table 2. Comparison of the mean results of venous blood gases in heparin (1000 IU/mL) and heparin (5000 IU/mL) samples.
Variable

Hydrogen ion logarithm
PCO2
Bicarbonate ion
Base excess
Percentage of venous
blood oxygen saturation
partial pressure of venous
oxygen

Heparin
(1000 IU/mL)

Heparin
(5000 IU/mL)

Heparin
(1000 IU/mL)

Heparin
(5000 IU/mL)

Test result

Median (Quartile
range)/Mean ± SD

Median (Quartile
range)/Mean ± SD

min

Max

min

max

P-value

(7.35-7.43)7.40
(37.75-45.70) 42.20
(24.35-28.40)26.10
(-0.75-2.25)1
14.31 ± 63.29

(7.36-7.43)7.40
(37.75-45.70) 42.
(24-28.50)25.90
(-1.6-1.6)0.3
14.30 ± 66.51

3.371
23.5
14.2
5.2
23.1

7.54
101.9
39.2
5.9
94.4

3.369
23.4
3.3
5.6
24.2

7.964
99.3
39.2
5.2
94.4

0.98
<0.001
<0.001
<0.001
<0.001

0.02
3.85
2.37
12.81
9.85

10.90 ± 34.40

11.17 ± 35.70

15

70

15

74

<0.001

10.27

common clot sample between heparin (1000 IU/mL)
and heparin (5000 IU/mL) samples, but the difference was not statistically signiﬁcant. There was no
difference between the heparin (5000 IU/mL) and
heparin (1000 IU/mL) groups in terms of clotting
percentage and the number of clots in the heparin
(1000 IU/mL) group was more than heparin (5000
IU/mL) group (Table 4). Table 5 also shows the oxygen intake of patients.

4. Discussion
The results of the present study revealed all parameters were signiﬁcant except hydrogen ion logarithm (PH) and clot formation.
Sample dilution is not a unique characteristic of
liquid heparin, as adding each liquid of a different
composition to the blood (e.g. normal saline) will
have a diluting effect. The fact that values of variables were statistically signiﬁcant in the two groups
could not be attributed to the effect of heparin
dilution because 0.5 cc of blood and 0.05 cc of heparin (1000 IU/mL) and heparin (5000 IU/mL) (same
blood dilution about 10%) were used in both groups
of this study.
The heparin concentration and dilution in this
study can be considered as a factor of insigniﬁcance
of the statistical results of the hydrogen ion logarithm (PH), which was consistent with the previous
studies [10, 26, 27], but inconsistent with studies by
Coppola [28], Ashutosh Kumar [29], and Gholami
[30] that suggested increasing heparin concentration
had a signiﬁcant effect on the results of hydrogen
ion logarithm (PH). Despite the acidity of the heparin solution, the logarithm of the blood hydrogen
ion (PH) is not affected by up to 40% heparin dilution due to the blood buffering capacity. In the
present study, as suggested by some studies, 1 mg/
cc concentration (200 UI/cc) was used in both
groups to prevent the false effect of heparin on the
results of the hydrogen ion logarithm (PH) [28, 31].

test statistics

The results of this study show that increasing the
heparin syringe concentration leads to a decrease in
the parameters of PCO2, bicarbonate ion (HCO3),
base excess (BE), which is consistent with the study
by Gholami et al., Zokaei et al., Ashutosh Kumar
et al., and Coppola et al.[26, 28, 30] suggesting that
increasing heparin concentration led to a decrease
in bicarbonate ion (HCO3) and PCO2 parameters,
but was not consistent with a study by Barabadi
et al.[10] suggesting that increasing heparin concentration had a signiﬁcant effect on PCO2parameter. Similarly, Gholami et al., Zokaie et al., and
Barabadi et al. showed that an increase in heparin
concentration led to a decrease in BE parameter [10,
26, 30], which was consistent with the present study.
The effect of dilution and excess heparin concentration can reduce PCO2, which has the greatest
effect. The concentration should be at least half the
volume of different blood syringes, and all the
heparin should be removed from the syringe [10, 32,
33]. In the present study, considering the control of
dilution effects and confounding factors, the significance of the results of this parameter is probably
due to higher heparin concentration in the heparin
(5000 IU/mL) group. On the other hand, considering
its acidic nature, excess heparin concentration reduces the metabolic parameters (HCO3 and BE) and
misdiagnosis of metabolic acidosis and leads to
misinterpretation and improper treatment, which
has little to do with the patient's underlying problems [10]. Bicarbonate ion (HCO3) is one of the most
important chemical buffers in the body, and buffers
combine with hydrogen ions to maintain the acidbase balance of the body to reduce the acidic effect
of heparin, thus reducing free bicarbonate ions.
Since the most abundant BE in blood plasma are
bicarbonate ions, so if more heparin concentration is
used to heparinize the syringe, the BE percentage
will also decrease [34, 35]. According to Coppola 's
study, the results of PCO2 and bicarbonate ion
(HCO3) are inversely related to the increase heparin

4.38
0.75
0.28
2.38

±
±
±
±

136.75
4.12
1.28
14.66

5 ± 140.4
0.70 ± 3.71
0.22 ± 1
2.28 ± 15.63

126.5
2.9
0.89
8.7

150.4
7.8
1.99
21.3

14.6
2.36
0.41
8

150.6
7
1.83
21.3

<0.001
<0.001
<0.001
<0.001

135
135
135
134
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concentration, and 10% dilution led to a signiﬁcant
reduction in PCO2 and bicarbonate ion (HCO3) [36,
37].
On the other hand, the present study showed that
increasing heparin concentration increased the PO2
and SO2, which was consistent with the studies by
Gholami et al. and Ashutosh Kumar et al. [29, 30],
but it was not consistent with the studies by Zokaie
et al., Coppola et al., Barabadi et al. [10, 26, 28]
showing no signiﬁcant difference in the results of
PO2 and PCO2. Also, according to the present
study, increasing the heparin concentration led an
increase in hemoglobin level, which was consistent
with the study by Coppola et al. [28] but inconsistent
with the study by Zokaie [26], which showed that
increasing heparin concentration led to a decrease
in hemoglobin levels.
Heparin has a relative oxygen pressure of
150 mmHg, which with increasing heparin concentration, the PO2 also increases. On the other hand,
increasing the heparin concentration and increasing
PO2 increases the SO2 concentration [28]. In Hopper's study, an 18.8%, and 34.1% dilutions of blood
sample with a PO2 of 100 mmHg resulted in a signiﬁcant increase in PO2 [38].
The increase hemoglobin concentration is probably due to its buffering property, and buffers, hemoglobin as the most important one, play a role in
maintaining the acid-base balance. . Also, considering its acidic nature,negatively-charged hemoglobin showed a stringer afﬁnity with oxygenþ2
molecules that hydrogen þ1 ion. Therefore, it increases the blood oxygen saturation percentage [39].
According to Zokaie et al., increasing heparin concentration reduces hemoglobin level considering its
the dilution effects [26], which is inconsistent with
the present study.
According to the present study, increasing the
heparin concentration led to a decrease in the potassium and calcium ions but an increase in the
sodium ion, which was consistent with studies by
Barabadi [10], but it was inconsistent with the study
by Coppola [28].
The elevated sodium level is due to the sodium
heparin salt and blood sodium (NaH2Po4) is blood
plasma buffer combined with hydrogen ions to
maintain acid-base balance in blood samples and
forms (NaH2Po4) and sodium ions due to the nature
of acidiﬁed the heparin concentration, resulting in
an increase in blood sodium ion level [40].
According to the results of the study by Sandler
et al., the sodium ion group in the heparin (5000 IU/
mL) was less affected than heparin (1000 IU/mL),
which is probably due to the higher sodium concentration added to the sample from liquid sodium
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Sodium
potassium
Calcium
hemoglobin

P-value
maximum
minimum
maximum
Median
(Quartile range)/Standard
deviation ± mean
Median
(Quartile range)/Standard
deviation ± mean

minimum

Heparin (5000 IU/mL)
Heparin (1000 IU/mL)
Heparin (5000 IU/mL)
Heparin (1000 IU/mL)
Variable

Table 3. Comparison of mean electrolytes and hemoglobin levels in heparin (1000 IU/mL) and heparin (5000 IU/mL) samples.

Test result

Degree of freedom

Test statistics
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Table 4. Frequency distribution of clot formation in heparin (1000 IU/mL) and heparin (5000 IU/mL) groups.
Variable

Clot formation in heparin (5000 IU/mL)

Clot formation in
heparin (1000 IU/mL)

Yes(number/percentage)
No(number/percentage)
Total
Yes(number/percentage)

Yes (number/percentage)

No (number/percentage)

Total

1(0.71)
1(0.71)
2(1.42)
1(0.71)

3(2.13)
136(96.45)
139(98.58)
3(2.13)

4(2.84)
137(97.16)
141(100)
4(2.84)

P ¼ 0.25.

patients admitted to CCU of 22 Bahman Hospital in
Neyshabur for their sincere efforts.

Table 5. Oxygen intake of patients.
Variable

Concentration
of oxygen

Percentage

The fraction of
inspired oxygen (O2)

21%
21-40%
>40%

88
8.52
2.84

140(99.3)

heparin, and this error is exacerbated at higher
liquid heparin concentrations [41]. Kumar Sahoo
and Hooper, excess liquid heparin due to its dilution and combination effects leads to a decrease in
the measurement of positively charged ions such as
potassium, calcium, and, on the other hand, there is
almost no potassium in liquid sodium heparin and
dilution of heparinized blood samples can lead to a
signiﬁcant reduction in potassium levels [18, 38]. In
general, the liquid heparin concentration should not
exceed 10 units per milliliter of blood, unless
specialized heparin is used to eliminate the effect of
heparin-binding activity of calcium [31].
The most important limitation of the present
study was the low sample size of the number of
participants, which limits the ability to generalize
the results of the present study. It is better to
conduct future studies on a larger sample size.

5. Conclusion
The results of the present study show a signiﬁcant
difference between two types of heparins groups in
terms of the results of all parameters. Overall,
heparin (1000 IU/mL) led to a less disruption in the
results of venous blood gases, and since it has not
signiﬁcantly increased the risk of clots, it is recommended to be used for venous blood gas sampling.
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